Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000898039 | SCV001042223 | benign | Polyglandular autoimmune syndrome, type 1 | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000898039 | SCV001460099 | uncertain significance | Polyglandular autoimmune syndrome, type 1 | 2020-04-20 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003922906 | SCV004742316 | likely benign | AIRE-related disorder | 2019-09-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |